PINZI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.864
AS - Asia 3.006
EU - Europa 2.287
SA - Sud America 504
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 73
OC - Oceania 5
Totale 10.844
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.734
IT - Italia 1.005
SG - Singapore 908
CN - Cina 737
HK - Hong Kong 426
BR - Brasile 390
VN - Vietnam 358
GB - Regno Unito 331
SE - Svezia 255
BD - Bangladesh 126
DE - Germania 116
RU - Federazione Russa 104
FI - Finlandia 99
ID - Indonesia 96
KR - Corea 85
IN - India 71
CA - Canada 60
NL - Olanda 60
FR - Francia 58
AR - Argentina 42
MX - Messico 40
UA - Ucraina 40
TR - Turchia 38
BG - Bulgaria 34
LT - Lituania 34
ES - Italia 30
IQ - Iraq 26
JP - Giappone 23
BE - Belgio 21
PL - Polonia 21
EC - Ecuador 19
VE - Venezuela 18
ZA - Sudafrica 18
AT - Austria 17
CO - Colombia 15
IE - Irlanda 15
PK - Pakistan 14
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
IR - Iran 12
EG - Egitto 9
KE - Kenya 9
PH - Filippine 9
SA - Arabia Saudita 8
TN - Tunisia 8
CH - Svizzera 7
MA - Marocco 7
UY - Uruguay 6
CL - Cile 5
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HR - Croazia 4
IL - Israele 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NP - Nepal 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
MY - Malesia 3
PE - Perù 3
PR - Porto Rico 3
PY - Paraguay 3
SC - Seychelles 3
SI - Slovenia 3
AL - Albania 2
AU - Australia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GE - Georgia 2
KH - Cambogia 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BJ - Benin 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
Totale 10.727
Salva come PNG Salva come JPEG
Città #
Santa Clara 633
Ashburn 547
Singapore 473
Hong Kong 413
Fairfield 406
Chandler 288
San Jose 245
Hefei 214
Nyköping 182
Woodbridge 171
Council Bluffs 161
Modena 156
Beijing 150
Seattle 139
London 135
Houston 132
Ho Chi Minh City 126
Cambridge 120
Wilmington 112
Milan 110
Southend 109
Los Angeles 100
Bologna 89
Hanoi 89
Ann Arbor 88
Helsinki 82
Seoul 81
The Dalles 81
Chicago 78
New York 75
Jakarta 74
San Diego 44
Princeton 41
Dearborn 38
Reggio Emilia 36
Shanghai 36
Jacksonville 35
São Paulo 34
Rome 33
Sofia 32
Dallas 31
Parma 31
Buffalo 29
Lauterbourg 29
Salt Lake City 28
Orem 24
Munich 23
Moscow 20
Naples 20
Tampa 20
Brussels 19
Tokyo 19
Elk Grove Village 18
Toronto 18
Warsaw 17
Boardman 16
Nuremberg 16
Chennai 15
Denver 15
Eugene 15
Haiphong 15
Mexico City 15
Kent 14
Rio de Janeiro 14
Mumbai 13
Poplar 13
Redondo Beach 13
Izmir 12
Phoenix 12
Amsterdam 11
Atlanta 11
Biên Hòa 11
Da Nang 11
Formigine 11
Frankfurt am Main 11
Lappeenranta 11
Stockholm 11
Vienna 11
Brooklyn 10
Dublin 10
Guangzhou 10
Johannesburg 10
Kilburn 10
Tashkent 10
Baghdad 9
Boston 9
Des Moines 9
Frattamaggiore 9
Miano 9
Montreal 9
Nairobi 9
Turin 9
Bari 8
Curitiba 8
Meana Sardo 8
Paris 8
Redwood City 8
Brasília 7
Brescia 7
Cagliari 7
Totale 7.024
Salva come PNG Salva come JPEG
Nome #
An unexpected reversal in the pharmacological stereoselectivity of benzothiadiazine AMPA positive allosteric modulators 376
On the integration of in silico drug design methods for drug repurposing 320
Molecular docking: Shifting paradigms in drug discovery 313
Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L. 310
Selection of protein conformations for structure-based polypharmacology studies 309
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 309
Identification of small-molecule EGFR allosteric inhibitors by high-Throughput docking 288
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease 288
Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank 285
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 282
Identification of 4-aryl-1H-pyrrole[2,3-b]pyridine derivatives for the development of new B-Raf inhibitors 272
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR 272
Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models 267
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 259
Design of dual inhibitors of histone deacetylase 6 and heat shock protein 90 251
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 250
Computational polypharmacology comes of age 240
LigAdvisor: A versatile and user-friendly web-platform for drug design 231
2-Phenyloxazole-4-carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B 223
Dual Targeting Strategies On Histone Deacetylase 6 (HDAC6) And Heat Shock Protein 90 (Hsp90) 221
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 220
Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity 218
Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies 203
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies 195
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 188
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing 184
Refinement and rescoring of virtual screening results 184
How drug repurposing can advance drug discovery: challenges and opportunities 181
Virtual screening for dual Hsp90/B-Raf inhibitors 178
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications 176
In silico repositioning of cannabigerol as a novel inhibitor of the enoyl acyl carrier protein (ACP) reductase (INHA) 174
Repositioning natural products in drug discovery 171
Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers 169
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase 167
Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors 166
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring 166
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 159
Development and application of LigAdvisor, a user-friendly web-platform for polypharmacology and drug repurposing 155
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B 147
Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction 144
On the development of B-Raf inhibitors acting through innovative mechanisms 138
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines 137
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR 134
LigAdvisor: a web server to perform in silico explorations on crystallographic ligands and known drugs for polypharmacology and drug repurposing. 120
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 119
LigAdvisor: a web platform designed for charting novel polypharmacology and drug repurposing routes from crystallographic ligands and known drugs 117
Exploring Biological Targets of Magnolol and Honokiol and their Nature-Inspired Synthetic Derivatives: In Silico Identification and Experimental Validation of Estrogen Receptors 114
Rational design of dual inhibitors of Hsp90 and B-Raf as a novel pharmacological approach against melanomas 113
Targeting the allosteric sites of the B-Raf protein kinase through an in silico approach 111
Trends and Applications in Computationally Driven Drug Repurposing 103
Polypharmacology predictions in the Protein Data Bank 98
Unveiling target associations for polypharmacology from analysis of crystallographic ligands in the Protein Data Bank 97
Tackling polypharmacology and drug repurposing with the LigAdvisor webserver. 95
Rational design of dual inhibitors of Hsp90 and Braf as a novel pharmacological approach against melanomas 90
Predicting drug polypharmacology using structural databases 83
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 18
Improving Machine Learning Classification Predictions through SHAP and Features Analysis Interpretation 16
Design, synthesis and biological activity of glycoconjugated ADAMTS5 exosite inhibitors: applications in osteoarthritis and ovarian cancer models 12
Selective imaging probes for differential detection of pathological tau polymorphs in tauopathies 11
Design, synthesis, and biological evaluation of chalcone derivatives as selective Monoamine Oxidase-B inhibitors with potential neuroprotective effects 7
Totale 10.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.373
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022807 67 41 48 52 19 36 49 61 88 54 192 100
2022/2023900 105 129 70 84 87 107 37 96 107 25 36 17
2023/2024772 28 44 52 73 138 55 98 111 17 14 48 94
2024/20252.503 63 19 66 185 482 309 133 182 215 279 255 315
2025/20264.141 284 183 345 548 590 212 492 189 425 382 335 156
2026/2027140 140 0 0 0 0 0 0 0 0 0 0 0
Totale 10.844